Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Improved vs original Compound Salvia Dropping Pills for stable angina
ChiCTR-TRC-09000576Phase 4Completed
- Sponsor
- Tasly Pharmaceutical Group Co., Ltd.
- Start
- Oct 2009
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Compound Salvia Dropping Pills in angina pectoris and coronary arteriosclerosis (2 arms), sponsored by Tasly Pharmaceutical Group Co., Ltd. Primary endpoint: Angina efficacy. Started Oct 2009; status: completed.
02
Drugs
Compound Salvia Dropping Pills
03
Conditions
angina pectoriscoronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR-TRC-09000576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-09000576.